questionsmedicales.fr
États, signes et symptômes pathologiques
Processus pathologiques
Caractéristiques de la maladie
Maladie chronique
Hépatite chronique
Hépatite chronique : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hépatite chronique : Questions médicales les plus fréquentes",
"headline": "Hépatite chronique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hépatite chronique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-22",
"dateModified": "2025-02-16",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hépatite chronique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladie chronique",
"url": "https://questionsmedicales.fr/mesh/D002908",
"about": {
"@type": "MedicalCondition",
"name": "Maladie chronique",
"code": {
"@type": "MedicalCode",
"code": "D002908",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.291.500"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hépatite B chronique",
"alternateName": "Hepatitis B, Chronic",
"url": "https://questionsmedicales.fr/mesh/D019694",
"about": {
"@type": "MedicalCondition",
"name": "Hépatite B chronique",
"code": {
"@type": "MedicalCode",
"code": "D019694",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.291.500.477.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hépatite C chronique",
"alternateName": "Hepatitis C, Chronic",
"url": "https://questionsmedicales.fr/mesh/D019698",
"about": {
"@type": "MedicalCondition",
"name": "Hépatite C chronique",
"code": {
"@type": "MedicalCode",
"code": "D019698",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.291.500.477.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hépatite D chronique",
"alternateName": "Hepatitis D, Chronic",
"url": "https://questionsmedicales.fr/mesh/D019701",
"about": {
"@type": "MedicalCondition",
"name": "Hépatite D chronique",
"code": {
"@type": "MedicalCode",
"code": "D019701",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.291.500.477.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hépatite chronique",
"alternateName": "Hepatitis, Chronic",
"code": {
"@type": "MedicalCode",
"code": "D006521",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Heiner Wedemeyer",
"url": "https://questionsmedicales.fr/author/Heiner%20Wedemeyer",
"affiliation": {
"@type": "Organization",
"name": "Department of Gastroenterology, Hepatology and Endocrinology, Medical School of Hanover, Hanover, Germany."
}
},
{
"@type": "Person",
"name": "Grace Lai-Hung Wong",
"url": "https://questionsmedicales.fr/author/Grace%20Lai-Hung%20Wong",
"affiliation": {
"@type": "Organization",
"name": "Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China."
}
},
{
"@type": "Person",
"name": "Giuseppina Brancaccio",
"url": "https://questionsmedicales.fr/author/Giuseppina%20Brancaccio",
"affiliation": {
"@type": "Organization",
"name": "Infectious Diseases, Department of Molecular Medicine, University of Padua, Padua, Italy."
}
},
{
"@type": "Person",
"name": "Giovanni B Gaeta",
"url": "https://questionsmedicales.fr/author/Giovanni%20B%20Gaeta",
"affiliation": {
"@type": "Organization",
"name": "Infectious Diseases, Department of Mental and Physical Health, Campania University, Naples, Italy. Electronic address: giovannibattista.gaeta@unicampania.it."
}
},
{
"@type": "Person",
"name": "Maria Buti",
"url": "https://questionsmedicales.fr/author/Maria%20Buti",
"affiliation": {
"@type": "Organization",
"name": "Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus and Universitat Autònoma de Barcelona, Barcelona, Spain."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Omega-3 polyunsaturated fatty acids in the brain and visual system: Focus on invertebrates.",
"datePublished": "2024-08-16",
"url": "https://questionsmedicales.fr/article/39154851",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cbpb.2024.111023"
}
},
{
"@type": "ScholarlyArticle",
"name": "Group efficiency based on the termination rule in the multiple-targets visual search task.",
"datePublished": "2024-08-15",
"url": "https://questionsmedicales.fr/article/39147959",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3758/s13423-024-02558-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Learning to ignore visual onset distractors hinges on a configuration-dependent coordinates system.",
"datePublished": "2024-08-15",
"url": "https://questionsmedicales.fr/article/39146045",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1037/xhp0001236"
}
},
{
"@type": "ScholarlyArticle",
"name": "Designing the Australian Cancer Atlas: visualizing geostatistical model uncertainty for multiple audiences.",
"datePublished": "2024-08-12",
"url": "https://questionsmedicales.fr/article/39135444",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1093/jamia/ocae212"
}
},
{
"@type": "ScholarlyArticle",
"name": "Visualization of Electrooxidation on Palladium Single Crystal Surfaces via In Situ Raman Spectroscopy.",
"datePublished": "2024-08-06",
"url": "https://questionsmedicales.fr/article/39107260",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/anie.202408736"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Processus pathologiques",
"item": "https://questionsmedicales.fr/mesh/D010335"
},
{
"@type": "ListItem",
"position": 4,
"name": "Caractéristiques de la maladie",
"item": "https://questionsmedicales.fr/mesh/D020969"
},
{
"@type": "ListItem",
"position": 5,
"name": "Maladie chronique",
"item": "https://questionsmedicales.fr/mesh/D002908"
},
{
"@type": "ListItem",
"position": 6,
"name": "Hépatite chronique",
"item": "https://questionsmedicales.fr/mesh/D006521"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hépatite chronique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hépatite chronique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hépatite chronique",
"description": "Comment diagnostiquer l'hépatite chronique ?\nQuels tests sanguins sont utilisés ?\nQu'est-ce qu'une biopsie hépatique ?\nQuels sont les signes d'hépatite chronique ?\nL'échographie est-elle utile ?",
"url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Visual+Perception&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hépatite chronique",
"description": "Quels sont les symptômes courants ?\nLa jaunisse est-elle un symptôme ?\nPeut-on avoir des symptômes asymptomatiques ?\nLes démangeaisons sont-elles fréquentes ?\nY a-t-il des symptômes psychologiques ?",
"url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Visual+Perception&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hépatite chronique",
"description": "Comment prévenir l'hépatite chronique ?\nLa vaccination est-elle efficace ?\nQuels comportements à risque éviter ?\nL'hygiène joue-t-elle un rôle ?\nLes tests de dépistage sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Visual+Perception&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hépatite chronique",
"description": "Quels traitements existent pour l'hépatite chronique ?\nLes antiviraux sont-ils efficaces ?\nQuand faut-il envisager une transplantation ?\nY a-t-il des traitements naturels ?\nComment surveiller l'évolution de la maladie ?",
"url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Visual+Perception&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hépatite chronique",
"description": "Quelles sont les complications possibles ?\nLa cirrhose est-elle réversible ?\nQuels signes indiquent une insuffisance hépatique ?\nLe cancer du foie est-il fréquent ?\nComment prévenir les complications ?",
"url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Visual+Perception&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hépatite chronique",
"description": "Quels sont les principaux facteurs de risque ?\nL'usage de drogues augmente-t-il le risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe sexe influence-t-il le risque ?\nLes voyages à l'étranger sont-ils un risque ?",
"url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Visual+Perception&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'hépatite chronique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins, des échographies et parfois une biopsie hépatique."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent les marqueurs viraux, les enzymes hépatiques et les tests de fonction hépatique."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'une biopsie hépatique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un prélèvement de tissu hépatique pour évaluer l'inflammation et les lésions."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'hépatite chronique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes peuvent inclure fatigue, jaunisse, douleurs abdominales et démangeaisons."
}
},
{
"@type": "Question",
"name": "L'échographie est-elle utile ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'échographie permet de visualiser des anomalies du foie et d'évaluer sa taille."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, jaunisse, douleurs abdominales et perte d'appétit."
}
},
{
"@type": "Question",
"name": "La jaunisse est-elle un symptôme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la jaunisse se manifeste par une coloration jaune de la peau et des yeux."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes asymptomatiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent être asymptomatiques malgré une hépatite chronique."
}
},
{
"@type": "Question",
"name": "Les démangeaisons sont-elles fréquentes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les démangeaisons peuvent survenir en raison de l'accumulation de bile dans le sang."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes psychologiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'anxiété et la dépression peuvent être des symptômes associés à l'hépatite chronique."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hépatite chronique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination, l'hygiène et l'évitement des comportements à risque sont essentiels."
}
},
{
"@type": "Question",
"name": "La vaccination est-elle efficace ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la vaccination contre l'hépatite A et B est très efficace pour prévenir ces infections."
}
},
{
"@type": "Question",
"name": "Quels comportements à risque éviter ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez le partage d'aiguilles, les rapports sexuels non protégés et l'usage de drogues."
}
},
{
"@type": "Question",
"name": "L'hygiène joue-t-elle un rôle ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne hygiène personnelle et alimentaire peut réduire le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage sont-ils importants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage régulier est crucial pour détecter l'hépatite chronique tôt."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour l'hépatite chronique ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des antiviraux, des immunomodulateurs et des soins de soutien."
}
},
{
"@type": "Question",
"name": "Les antiviraux sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antiviraux peuvent réduire la charge virale et améliorer la fonction hépatique."
}
},
{
"@type": "Question",
"name": "Quand faut-il envisager une transplantation ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La transplantation est envisagée en cas d'insuffisance hépatique sévère ou de complications graves."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains traitements naturels peuvent aider, mais ils doivent être discutés avec un médecin."
}
},
{
"@type": "Question",
"name": "Comment surveiller l'évolution de la maladie ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suivis réguliers avec des tests sanguins et des échographies sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la cirrhose, le cancer du foie et l'insuffisance hépatique."
}
},
{
"@type": "Question",
"name": "La cirrhose est-elle réversible ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la cirrhose est une condition irréversible, mais son évolution peut être ralentie."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une insuffisance hépatique ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent confusion, saignements, jaunisse et accumulation de liquide abdominal."
}
},
{
"@type": "Question",
"name": "Le cancer du foie est-il fréquent ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le cancer du foie peut survenir chez les patients atteints d'hépatite chronique."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et un traitement approprié peuvent aider à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'infection virale, l'alcoolisme, et certaines maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "L'usage de drogues augmente-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'usage de drogues injectables augmente le risque d'hépatite chronique."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux d'hépatite peuvent augmenter le risque de développer la maladie."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains groupes de sexe peuvent avoir un risque plus élevé d'infection virale."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger sont-ils un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des régions à forte prévalence d'hépatite peut augmenter le risque d'infection."
}
}
]
}
]
}
A critical role of omega-3 polyunsaturated fatty acids (PUFA), mainly docosahexaenoic acid 22:6ω3 (DHA), in the development and function of the brain and visual system is well established. DHA, the mo...
In practical visual search fields, observers often encounter errors that result from an unknown number of targets, which may induce reduced accuracy and speed. Our current study addresses the potentia...
Decrement of attentional capture elicited by visual onset distractors, consistent with habituation, has been extensively characterized over the past several years. However, the type of spatial frame o...
The Australian Cancer Atlas (ACA) aims to provide small-area estimates of cancer incidence and survival in Australia to help identify and address geographical health disparities. We report on the 21-m...
The preliminary phases included a scoping study, literature review, and target audience focus groups. Several methods were used to reach the wide target audience. The design and development stage incl...
The initial scoping identified 4 target audience groups: the general public, researchers, health practitioners, and policy makers. These target groups were consulted throughout the project to ensure t...
We reflect on the methods, design iterations, decision-making process, and document lessons learned for future atlases....
The ACA has been hugely successful since launching in 2018. It has received over 62 000 individual users from over 100 countries and across all target audiences. It has been replicated in other countr...
The electrooxidation of catalyst surfaces is across various electrocatalytic reactions, directly impacting their activity, stability and selectivity. Precisely characterizing the electrooxidation on w...
To use bibliometric methods to analyze the research hotspots and future development trends regarding the application of mesenchymal stem cells in peripheral nerve injury and regeneration....
Articles published from January 1, 2013, to December 31, 2023, were meticulously screened using the MeSH terms: TS = ("Mesenchymal stem cells" AND "Peripheral nerve injury") OR TS = ("Mesenchymal stem...
An extensive search of the Web of Science database yielded 350 relevant publications. These scholarly works were authored by 2,049 collaborative researchers representing 41 countries and affiliated wi...
Over the past decade, there has been a consistent upward trajectory in the number of publications and citations pertaining to the use of mesenchymal stem cells in the realm of peripheral nerve injury ...
The analysis of meta-omics data requires the utilization of several bioinformatics tools and proficiency in informatics. The integration of multiple meta-omics data is even more challenging, and the o...
Live cell imaging is essential for obtaining spatial and temporal insights into dynamic molecular events within heterogeneous individual cells, in situ intracellular networks, and in vivo organisms. M...
This current study is based on a set of visual motion sensitivity tests, investigating the correlation between visual motion sensitivity and diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM...
This research was conducted by a combination of questionnaire collection and on-site investigation that involved 542 T2DM recruited from a community. The visual motion sensitivity determined the visua...
Among 542 subjects, there are 162 cases of DR, with a prevalence rate of 29.89%. After adjusting factors of age, gender, glycated hemoglobin, duration of diabetes, BMI, and hypertension, we found that...
Visual motion sensitivity especially for the second-order high spatial frequency stimuli emerges as a significant predictor of DR in T2DM, offering a sensitive diagnostic tool for early detection....
Fermentative production of natural colorants using microbial strains has emerged as a cost-effective and sustainable alternative to chemical synthesis. Visual pigments are used as signal outputs in co...